Concepedia

Christopher D. Hepler

CD

Statistics

Publications

3

Citations

245

H-Index

3

Active since

2004

Affiliations

Eli Lilly (United States)(Current)

Christopher D. Hepler is an author at Eli Lilly (United States) specializing in toxicology, marine chemistry, and molecular pharmacology.

Top concepts

Publications per year

2004–2012

3

Publications

3

T0901317 is a dual LXR/FXR agonist

Keith A. Houck, Kristen M. Borchert, Christopher D. Hepler et al. · Molecular Genetics and Metabolism · 2004 · 182 citations

, ,

Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine

Terry A. Hauser, Christopher D. Hepler, David C. Kombo et al. · Neuropharmacology · 2012 · 48 citations

, , +8

Structure–Activity Studies of 7-Heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A Novel Class of Highly Potent Nicotinic Receptor Ligands

Scott R. Breining, Matt S. Melvin, Balwinder S. Bhatti et al. · Journal of Medicinal Chemistry · 2012 · 15 citations · Full text

1–3 of 3